Medisights Pioneers New Standard: AI Agents Capture Unprecedented Near Real-Time Market Intelligence in Complex Diseases Like Multiple Myeloma

Summary

Medisights announced the completion of a landmark study demonstrating that AI agents can provide near real-time market intelligence for complex diseases including multiple myeloma. The announcement highlights the company's AI-native platform capabilities for life sciences applications.